CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-05-29 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −400,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −450,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −500,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −500,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −402,500 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −402,500 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Returned to the company · Stock Option (Right to Buy) | −225,000 | 0 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-05-29 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 |
Page 2 of 39 · 768 trades